国际眼科杂志2016，Vol.16Issue(12)：2329-2331,3.DOI:10.3980/j.issn.1672-5123.2016.12.43
玻璃体腔内注射康柏西普治疗视网膜静脉阻塞继发黄斑水肿
Clinical observation of intravitreal injection of Conbercept for the treatment of macular edema secondary to retinal vein occlusion
秦书艳 1沈磊 1力强1
作者信息
- 1. 223800 中国江苏省宿迁市，南京鼓楼医院集团宿迁市人民医院眼科
- 折叠
摘要
Abstract
•AIM: To investigate the clinical effect and safety of intravitreal injection of Conbercept for the treatment of macular edema secondary to retinal vein obstruction.•METHODS: A total of 22 patients with macular edema secondary to retinal vein occlusion were treated in our hospital during January 2016 to Marth 2016. A total of 22 patients were given three intravitreal injections of Conbercept 0. 05mL (0. 5mg). Defore and after treatment, best-corrected visual acuity, fundus photography,fundus fluoreseein angiograph ( FFA ) , optical coherence tomography( OCT) were examined.•RESULTS: A total of 22 patients were treated with intravitreal injection of Conbercept had different degrees of increase in the mean visual acuity at 1wk, 1, 2 and 3mo. The difference is statistically significant (P<0. 05). OCT images show that the thickness of the central retinal thickness of the macular becomes thinner, and the difference is statistically significant (P<0. 05). The FFA at 3mo showed a significant reduction in retinal leakage, obvious absorption of retinal hemorrhage.•CONCLUSION:Intravitreal injection of anti-VEGF drugs Conbercept is an effective way to treat macular edema secondary to retinal vein occlusion, it is worth to promot, but the long-term efficacy and drug injection frequency still need to study further.关键词
视网膜静脉阻塞/黄斑水肿/康柏西普Key words
Conbercept/macular edema/retinal vein occlusion引用本文复制引用
秦书艳,沈磊,力强..玻璃体腔内注射康柏西普治疗视网膜静脉阻塞继发黄斑水肿[J].国际眼科杂志,2016,16(12):2329-2331,3.
